The influence of PSA flare in mCRPC patients treated with alpha-emitting radiopharmaceuticals

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2253-2255. doi: 10.1007/s00259-018-4162-5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms, Castration-Resistant
  • Radiopharmaceuticals*
  • Retrospective Studies
  • Taxoids

Substances

  • Radiopharmaceuticals
  • Taxoids
  • Prostate-Specific Antigen